SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001493152-24-009093
Filing Date
2024-03-06
Accepted
2024-03-06 18:00:51
Documents
1
Period of Report
2024-03-04

Document Format Files

Seq Description Document Type Size
1 ownership.html 4  
1 ownership.xml 4 4002
  Complete submission text file 0001493152-24-009093.txt   5391
Mailing Address 1901 W. 47TH PLACE KANSAS CITY KS 66205
Business Address 1901 W. 47TH PLACE KANSAS CITY KS 66205 (913) 942-2300
Cingulate Inc. (Issuer) CIK: 0001862150 (see all company filings)

IRS No.: 863825535 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O CINGULATE INC. 1901 W. 47TH PLACE KANSAS CITY KS 66205
Business Address
Schaffer Shane J. (Reporting) CIK: 0001883254 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-40874 | Film No.: 24727389